1-3 of 3
Ramana Reddy, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Striking Reduction of Monoclonal Protein in a Patient with Concurrent Plasma Cell Dyscrasia and CMML-2, after Treatment with Rigosertib (01910.Na)

Jamile M. Shammo, MD, Agne Paner, MD, MV Ramana Reddy, PhD, Rachel L Mitchell, MD, Parameswaran Venugopal, MD
Journal: Blood
Blood (2015) 126 (23): 5362.
https://doi.org/10.1182/blood.V126.23.5362.5362
Published: 2015
Journal Articles

Rigosertib Blocks RAS Signaling By Acting As a Small Molecule RAS Mimetic That Binds to the RAS-Binding Domains of RAS Effector Proteins

E. Premkumar Reddy, PhD, Sai Krishna Divakar, PhD, Rodrigo Vasquez-Del Carpio, PhD, Kaushik Dutta, PhD, Stacey J Baker, PhD, Ramana Reddy, PhD, Aneel K Aggarwal, PhD
Journal: Blood
Blood (2014) 124 (21): 5616.
https://doi.org/10.1182/blood.V124.21.5616.5616
Published: 2014
Journal Articles

Suppression of Cyclin D1 by on 01910.Na Is Associated with Decreased Survival of Trisomy 8 Myelodyplastic Bone Marrow Progenitors: A Potential Targetted Therapy.

Elaine M. Sloand, MD, Loretta Pfannes, Ramana Reddy, PhD, Premkumar Reddy, PhD, Jerome S. Groopman, MD, Neal S. Young, MD
Journal: Blood
Blood (2007) 110 (11): 822.
https://doi.org/10.1182/blood.V110.11.822.822
Published: 2007